Skip to content
Screener

Xencor XNCR Total Revenue

Total Revenue at other companies

Amgen logo
AmgenAMGN
$10.05B+9.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$4.29B+16.7%
Janux Therapeutics logo
Janux TherapeuticsJANX
$10.27M
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$4.05M-76.3%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$25.56M-8.0%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$0

Other financials

Income statement

See full
Operating income-$37.1M-11.7%
Net income-$21.7M+29.5%
EPS (diluted)-$0.29+29.3%

Balance sheet

See full
Cash & equivalents$44.7M+0.5%
Total debt$170.1M-20.1%
Total equity$503.2M-18.9%
Total assets$725.0M-17.6%

Cash flow

See full
Operating cash flow-$55.7M-53.0%
CapEx$538.0K+40.5%
Free cash flow-$56.2M-52.9%

Valuation

See full
Market cap$1.55B+210%
Enterprise value$1.67B+150%
P/S14.7×+11.3×

Profitability

See full
Operating margin-205.8%-2,501pp
Net margin-155.6%+78.8pp
FCF margin-198.4%-1,485pp

Returns & leverage

See full
Return on equity-29.1%+0.2pp
Debt / equity0.3×0.0×
Current ratio6.4×+1.1×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Xencor’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:02 PM EDT
Fiscal quarter
Q4 FY2028
Calendar quarter
Q4 2028
Accession
0001326732-26-000056
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenue
Collaborations, milestones, and royalties$51,221$43,608$55,737$76,340
Operating expenses:
Research and development71,90561,665136,574120,243
General and administrative16,38415,11534,09332,452
Total operating expenses88,28976,780170,667152,695
Operating loss(37,068)(33,172)(114,930)(76,355)
Other income (expense):

Item 1. Financial Statements

FAQ

What is Xencor's total revenue?
Xencor (XNCR) reported total revenue of $51.22M in Q2 2026.
How has Xencor's total revenue changed year-over-year?
Xencor's total revenue increased by 17.5% year-over-year, from $43.61M to $51.22M.
What is the long-term trend for Xencor's total revenue?
Over 4 years (2021 to 2025), Xencor's total revenue has grown at a -17.8% compound annual growth rate (CAGR), from $275.11M to $125.58M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Xencor's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude